Type
Offshoring/Delocalisation
Country
France
Region
Méditerranée; Provence-Alpes-Côte d\'Azur; Alpes-Maritimes
Location of affected unit(s)
Biot
Sector
Manufacturing
Manufacturing Of Furniture And Other Manufacturing
Other Manufacturing
32.50 - Manufacture of medical and dental instruments and supplies
New offshoring locations
Switzerland

102 jobs
Number of planned job losses
Job loss
Announcement Date
14 December 2020
Employment effect (start)
1 April 2021
Foreseen end date
30 June 2022

Description

Integra Neurosciences Implants France has announced the closure of its plant at Biot (Alpes maritimes) which employs 124 people, to transfer production to a plant in Switzeland by June 2022. This transfer represents 80% of production. Employees now fear 102 redundancies. The Social and Economic Committee is due to sign the agreement on 29 January 2021, and the labour inspectorate has ten days to give its opinion. It means that from Februar 2021, employees that will leave the company will not be replaced. 

The employees went on strike on 14 December and demonstrated in front of the site where they produce valves, electrodes and catheters for use in neurosurgery. Integra employs 500 people in Europe, including about 400 in France. For the management, priority is given to supporting employees 'in their return to work, whether internally or externally, after the planned closure of this site in June 2022'.


Sources

Citation

Eurofound (2020), Integra Neurosciences Implants, Offshoring/Delocalisation in France, factsheet number 102907, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/102907.